V-Med FRAG 176-191 2500 mcg
V-Med FRAG 176-191 2500 mcg
V-Med FRAG 176-191 2500 mcg
FRAG 176-191 is a modified peptide fragment of human growth hormone. It is the section of the growth hormone molecule responsible for the specific fat-mobilising actions of GH without the full growth hormone activity. This has made FRAG 176-191 popular among metabolic and weight management researchers. In research environments FRAG has shown the ability to increase fat breakdown and reduce new fat formation especially in stubborn adipose areas.
CATEGORY: Growth Hormones / Peptides
CONTENT:
PRESENTATION SIZE: 10 ml nasal spray bottle
STRENGTH: 2500 mcg
TOTAL STRENGTH: 2500 mcg per 10 ml bottle
DESCRIPTION:
FRAG 176-191 is a modified peptide fragment of human growth hormone. It is the section of the growth hormone molecule responsible for the specific fat-mobilising actions of GH without the full growth hormone activity. This has made FRAG 176-191 popular among metabolic and weight management researchers. In research environments FRAG has shown the ability to increase fat breakdown and reduce new fat formation especially in stubborn adipose areas.
Properties and Effects
Supports fat breakdown in stubborn fatty tissue
Does not demonstrate the full growth hormone actions connected to blood glucose elevation
Shows preference for lipolysis rather than muscle or organ tissue signalling
Suitable for metabolic research where targeted fat loss activity is the focus
May support improved body composition as part of a structured regimen
Mechanism of Action
FRAG 176-191 binds to receptors which influence lipid metabolism. It activates pathways involved in fat cell breakdown known as lipolysis and decreases lipogenesis the process of new fat creation. Because FRAG is only a small section of the original GH sequence it does not activate many of the normal growth hormone pathways and therefore may show metabolic selectivity.
Recommended Use
Nasal delivery provides a non-injectable route for this peptide. Researchers typically apply FRAG protocols in cycles with body composition focus. FRAG works best when combined with consistent nutrition hydration and physical activity. Results are gradual and dependent on cumulative application over time.
Safety and Side Effects
FRAG 176-191 is still considered investigational. Possible mild side effects may include nasal irritation dryness or sneezing due to the nasal carrier medium. Individuals with sinus issues or allergies to preservatives should exercise caution. Always use sterile technique to avoid contamination of the nasal tip and avoid sharing the sprayer with other individuals.
Special Notes
Store upright in a cool stable environment protected from light and use within appropriate time frames after opening. This product has not been evaluated or approved as treatment for disease. Not intended for pregnant or breastfeeding individuals.
